Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | PDE10A | Q9Y233 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | KDM1A | O60341 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.36 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.35 |
| ▸ | DHODH | Q02127 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.35 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 3/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11946999 | 0.87 | MAPT (0.49) | MAPTMAPK1RAB9APDE10ATDP1 | |
| SCHEMBL11947014 | 0.87 | KDM4E (0.44) | MAPTPDE10ATDP1GAAMEN1 | |
| SCHEMBL12207665 | 0.87 | MAPT (0.49) | MAPTMAPK1RAB9APDE10ATDP1 | |
| SCHEMBL11947012 | 0.86 | PDE10A (0.43) | RAB9APDE10ATDP1KDM1ASIGMAR1 | |
| SCHEMBL14018416 | 0.86 | KDM4E (0.42) | MAPTPDE10ATDP1GAAMEN1 | |
| SCHEMBL12207640 | 0.86 | KDM4E (0.42) | MAPTPDE10ATDP1GAAMEN1 | |
| SCHEMBL12690630 | 0.86 | KDM4E (0.42) | MAPTPDE10ATDP1GAAMEN1 | |
| SCHEMBL12690829 | 0.86 | MAPT (0.48) | MAPTMAPK1RAB9APDE10ATDP1 | |
| SCHEMBL12207312 | 0.86 | TDP1 (0.50) | MAPTMAPK1RAB9APDE10ATDP1 | |
| SCHEMBL12207639 | 0.86 | KDM4E (0.42) | MAPTPDE10ATDP1GAAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8758905-B2 | Quinoxaline derivative, and organic semiconductor device, electric field light emitting device, and electronic device which have the same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-06-24 | — | — | US | disclosed |
| US-8758905-B2 | Quinoxaline derivative, and organic semiconductor device, electric field light emitting device, and electronic device which have the same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-06-24 | — | — | US | disclosed |
| US-20120286257-A1 | Quinoxaline Derivative, and Organic Semiconductor Device, Electric Field Light Emitting Device, and Electronic Device Which have the Same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-11-15 | — | — | US | disclosed |
| US-20120286257-A1 | Quinoxaline Derivative, and Organic Semiconductor Device, Electric Field Light Emitting Device, and Electronic Device Which have the Same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-11-15 | — | — | US | disclosed |
| US-8231984-B2 | Quinoxaline derivative, and organic semiconductor device, electric field light emitting device, and electronic device which have the same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-07-31 | — | — | US | disclosed |
| US-8231984-B2 | Quinoxaline derivative, and organic semiconductor device, electric field light emitting device, and electronic device which have the same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-07-31 | — | — | US | disclosed |
| US-20100069636-A1 | Quinoxaline Derivative, and Organic Semiconductor Device, Electric Field Light Emitting Device, and Electronic Device Which Have the Same | SEMICONDUCTOR ENERGY LABORATORY CO. LTD. | 2010-03-18 | — | — | US | disclosed |
| US-20100069636-A1 | Quinoxaline Derivative, and Organic Semiconductor Device, Electric Field Light Emitting Device, and Electronic Device Which Have the Same | SEMICONDUCTOR ENERGY LABORATORY CO. LTD. | 2010-03-18 | — | — | US | disclosed |
| US-7601435-B2 | Quinoxaline derivative, and organic semiconductor device, electric field light emitting device, and electronic device which have the same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2009-10-13 | — | — | US | disclosed |
| US-7601435-B2 | Quinoxaline derivative, and organic semiconductor device, electric field light emitting device, and electronic device which have the same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2009-10-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100069636-A1 | Quinoxaline Derivative, and Organic Semiconductor Device, Electric Field Light Emitting Device, and Electronic Device Which Have the Same | GRK1, NQO2, ARL1 | MAPT 3752/4885MAPK1 1125/4885RAB9A 1021/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.